Bupivacaine Hydrochloride Injection Recalled for Temperature Storage Deviations
McKesson Medical-Surgical is recalling Bupivacaine Hydrochloride Injection due to temperature abuse during storage that may have compromised product sterility. The recall affects 224 cartons distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II temperature-abuse deviation of a preservative-free injectable product presents a potential sterility compromise. This constitutes a risk-of-harm product category where no illnesses or injuries have been reported in the source.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Bupivacaine Hydrochloride Injection, 0.5% concentration in 10mL single-dose vials (preservative free). A total of 224 cartons have been distributed nationwide to healthcare facilities and distributors.
The recall was initiated due to temperature abuse deviations from Current Good Manufacturing Practice (cGMP) standards during product storage and shipment. Temperature fluctuations can compromise the sterility assurance of preservative-free injectable products, which rely entirely on aseptic manufacturing and handling to prevent contamination.
Affected customers have been notified by McKesson Medical-Surgical Inc. with specific information about distribution dates and impacted product shipment dates. Healthcare facilities and distributors should follow the recall instructions provided by the recalling firm.
The recalled product
- Product
- BUPIVACAINE HYDROCHLORIDE (BUPIVACAINE HYDROCHLORIDE)
- Brand
- BUPIVACAINE HYDROCHLORIDE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Hazard
- temperature-abuse
- sterility-compromise
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (8)
- 0355150170302
- 0355150250509
- 0355150249503
- 0355150168309
- 0355150169108
- 0355150167104
- 0355150172306
- 0355150171101
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · BUPIVACAINE HYDROCHLORIDE
- HighBupivacaine Hydrochloride Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-04-22
- HighBupivacaine Hydrochloride Injection Recalled Due to Manufacturing Temperature Deviations
FDA (Drugs) · 2022-06-15
- SevereBupivacaine and Lidocaine Injection Vials Recalled for Label Mix-Up
FDA (Drugs) · 2021-06-09
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27